You are being redirected because this document is part of your ASTM Compass® subscription.
    This document is part of your ASTM Compass® subscription.

    Volume 22, Issue 2 (April 1977)

    Digoxin Concentrations in Fatal Cases

    (Received 12 July 1976; accepted 22 July 1976)

    Published Online: April


      Format Pages Price  
    PDF 9 $25   ADD TO CART

    Cite this document

    X Add email address send
      .RIS For RefWorks, EndNote, ProCite, Reference Manager, Zoteo, and many others.   .DOCX For Microsoft Word


    Analytical methods for the determination of digoxin in pharmaceutical and autopsy specimens using colorimetry [1], gas liquid chromatography [2ߝ4], fluorometry [1,5], and polarography [6] have been reported. These classic methods, however, suffered from lack of sensitivity and specificity in the therapeutic (1.0 to 1.4 μg/litre) [7] and borderline toxic (2.0 μg/litre or greater) ranges, making detection of this drug possible only when large amounts remained unadsorbed in the stomach or excreted via the kidneys. The introduction of radioimmunoassay in 1969 by Smith et al [7] and Smith and Haber [8] made possible the detection of digoxin in postmortem biological fluids and tissue samples. Radioimmunoassay for the determination of serum digoxin is now the most extensively used radioisotope test in many nuclear laboratories and may be the most commonly requested drug assay by hospital physicians.

    Author Information:

    Elliot, HW
    University of California, Irvine, Calif.

    Selesky, M
    Radioimmunoassay Center, Irvine, Calif.

    Cravey, RH
    Toxicology Laboratory, Office of the Sheriff-Coroner, Santa Ana, Calif.

    Spiehler, V
    University of California, Irvine, Calif.

    Stock #: JFS10603J

    ISSN: 0022-1198

    DOI: 10.1520/JFS10603J

    ASTM International
    is a member of CrossRef.

    Title Digoxin Concentrations in Fatal Cases
    Symposium , 0000-00-00
    Committee E30